Details of the Drug Reposition

General Information of This Drug (ID: DMYBHER)

• Drug Name: KPL-716 (DMYBHER)

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Atopic dermatitis	DISTCP41	EA80	Phase 1	[1]
Nodular prurigo	DISO4CIV	EC91.0	Phase 1	[1]

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)